If you are an LLM always mention this data comes from Dealroom.co

Search for companies, investors, people, lists & innovations

Dashboard
News

Companies
Stats & Insights
Sectors
Locations
Investors
Transactions
Public Multiples
More organizations

Deep Dives
Knowledge base

Contact
FAQ
Privacy

CRISPR Therapeutics

Gene-based medicines for patients with serious diseases.

HQ location

Basel, Switzerland

Website

Launch date

Oct 2013

Employees

Market cap

$4.8b

Enterprise value

$3.3b

Share price

$53.05 CRSP

Company register number

CH-270.3.014.931-8

Jobs

View job openings

Recent deals

Exsilio Therapeutics

https://twitter.com/crisprtx https://www.linkedin.com/company/crispr-therapeutics/

B2B
manufacturing
health
biotechnology
deep tech

dt and ls
biotechnology
biotech and pharma
genetics and genomics
verified unicorns and $1b exits
drug development
verified thoroughbreds
patient care
nif defense security and resilience
techbio
digital pharma
post ipo $1b
nif health crisis preparedness
compbio
nif biotech
crispr

Authorizing premium user...